Salidroside suppresses group 2 innate lymphoid cell-mediated allergic airway inflammation by targeting IL-33/ST2 axis
- 1 April 2020
- journal article
- research article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 81, 106243
- https://doi.org/10.1016/j.intimp.2020.106243
Abstract
No abstract availableFunding Information
- National Key R&D Program of China (2016YFC1304000, 2016YFC1304002)
This publication has 34 references indexed in Scilit:
- The immunology of asthmaNature Immunology, 2014
- Enhanced innate type 2 immune response in peripheral blood from patients with asthmaJournal of Allergy and Clinical Immunology, 2014
- The Effect of Synthetic Salidroside on Cytokines and Airway Inflammation of Asthma Induced by Diisocyanate (TDI) in Mice by Regulating GATA3/T-betInflammation, 2014
- Anti-asthma effects of synthetic salidroside through regulation of Th1/Th2 balanceChinese Journal of Natural Medicines, 2014
- Eosinophils and the Ovalbumin Mouse Model of AsthmaPublished by Springer Science and Business Media LLC ,2014
- Inhibitory Effects of Salidroside on Nitric Oxide and Prostaglandin E2Production in Lipopolysaccharide-Stimulated RAW 264.7 MacrophagesJournal of Medicinal Food, 2013
- IL-33 is more potent than IL-25 in provoking IL-13–producing nuocytes (type 2 innate lymphoid cells) and airway contractionJournal of Allergy and Clinical Immunology, 2013
- Adjuvant effects of salidroside fromRhodiola roseaL. on the immune responses to ovalbumin in miceImmunopharmacology and Immunotoxicology, 2011
- Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cellsNature, 2009
- Is Th1 the solution for Th2 in asthma?Clinical & Experimental Allergy, 2002